Cost-effectiveness of Pegfilgrastim versus Filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma - HAL-SHS - Sciences de l'Homme et de la Société Accéder directement au contenu
Communication Dans Un Congrès Année : 2011

Cost-effectiveness of Pegfilgrastim versus Filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma

Fichier non déposé

Dates et versions

halshs-00628829 , version 1 (04-10-2011)

Identifiants

  • HAL Id : halshs-00628829 , version 1

Citer

Lionel Perrier, Anne Lefranc, Philippe Quittet, Philippe Moreau, Carole Siani, et al.. Cost-effectiveness of Pegfilgrastim versus Filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma. 16th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Baltimore, Etats-Unis, 25 mai 2011, May 2011, Baltimore, United States. ⟨halshs-00628829⟩
282 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More